About Cytecare
Cytecare is a company based in Bengaluru (India) founded in 2014 by Suresh Ramu, Himanshu Shah, Ferzaan Engineer, and Anthony Pais was acquired by Omega Hospitals in November 2025.. Cytecare has raised $78.45 million across 6 funding rounds from investors including Goldman Sachs, Omega Hospitals and Cytespace Research. The company has 256 employees as of August 19, 2025. Cytecare operates in a competitive market with competitors including HCG, Omega Hospitals, CION Cancer Clinics, American Oncology Institute and Mahatma Gandhi Cancer Hospital, among others.
- Headquarter Bengaluru, India
- Employees 256 as on 19 Aug, 2025
- Founders Suresh Ramu, Himanshu Shah, Ferzaan Engineer, Anthony Pais
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cytecare Hospitals Private Limited
- Date of Incorporation 11 Mar, 2014
- Jurisdiction Ahmedabad, Gujarat, India
-
Annual Revenue
$10.88 M (USD)18.72as on Mar 31, 2024
-
Net Profit
$-1.76 M (USD)60.15as on Mar 31, 2024
-
EBITDA
$-13.07 K (USD)98.54as on Mar 31, 2024
-
Total Equity Funding
$78.45 M (USD)
in 6 rounds
-
Latest Funding Round
$1.89 M (USD), Series B
Jul 20, 2022
-
Investors
Goldman Sachs
& 42 more
-
Employee Count
256
as on Aug 19, 2025
-
Acquired by
Omega Hospitals
(Nov 05, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Cytecare
Cytecare has successfully raised a total of $78.45M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $1.89 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series B — $1.9M
-
First Round
First Round
(21 May 2014)
- Investors Count 42
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2022 | Amount | Series B - Cytecare | Valuation | Canadian International Health Education Association |
|
| Nov, 2020 | Amount | Series B - Cytecare | Valuation | Cytespace Research | |
| Jul, 2019 | Amount | Series B - Cytecare | Valuation | Goldman Sachs , Gi Global Health |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cytecare
Cytecare has secured backing from 43 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Goldman Sachs, Omega Hospitals and Cytespace Research. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment banking services are delivered across multiple financial sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is provided to tech startups by the fund.
|
Founded Year | Domain | Location | |
|
Seed-stage investments are targeted by Jacesa Investments venture capital firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cytecare
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cytecare
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cytecare Comparisons
Competitors of Cytecare
Cytecare operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as HCG, Omega Hospitals, CION Cancer Clinics, American Oncology Institute and Mahatma Gandhi Cancer Hospital, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Chain of oncology hospitals
|
|
| domain | founded_year | HQ Location |
Specialized oncology treatments are offered by a hospital chain.
|
|
| domain | founded_year | HQ Location |
Cancer treatments and support are provided by a clinic chain.
|
|
| domain | founded_year | HQ Location |
Cancer care is provided through a chain of specialized hospitals.
|
|
| domain | founded_year | HQ Location |
Cancer care is delivered via a chain of accredited hospitals.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cytecare
Frequently Asked Questions about Cytecare
When was Cytecare founded?
Cytecare was founded in 2014.
Where is Cytecare located?
Cytecare is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Who is the current CEO of Cytecare?
Suresh Ramu is the current CEO of Cytecare. They have also founded this company.
Is Cytecare a funded company?
Cytecare is a funded company, having raised a total of $78.45M across 6 funding rounds to date. The company's 1st funding round was a Series B of $4.01M, raised on May 21, 2014.
How many employees does Cytecare have?
As of Aug 19, 2025, the latest employee count at Cytecare is 256.
What is the annual revenue of Cytecare?
Annual revenue of Cytecare is $10.88M as on Mar 31, 2024.
What does Cytecare do?
Chain of oncology hospitals. It specializes in a wide range of cancer treatments, including advanced surgical care, Pediatric, Interventional, Uro Neuro oncology, Bone Marrow transplant, Gastrointestinal Cancer Treatment, Pain and Palliative Care, chemotherapy, ENT care, radiotherapy, Organ-Site Focused Care, Holistic Patient Support, Advanced Diagnostic Services, and more.
Who are the top competitors of Cytecare?
Cytecare's top competitors include HCG, CION Cancer Clinics and Omega Hospitals.
Who are Cytecare's investors?
Cytecare has 43 investors. Key investors include Goldman Sachs, Omega Hospitals, Cytespace Research, Shanghvi Finance, and Synergy AG.
What is Cytecare's valuation?
The valuation of Cytecare is $34.1M as of Jul 2022.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.